Cargando…

Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy

BACKGROUND: Acute myeloid leukemia (AML) is a hematopoietic malignancy with a prognosis that varies with genetic heterogeneity of hematopoietic stem/progenitor cells (HSPCs). Induction chemotherapy with cytarabine and anthracycline has been the standard care for newly diagnosed AML, but about 30% of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Ruinan, Ji, Min, Li, Guosheng, Xia, Yuan, Guo, Shouhui, Li, Peng, Sun, Yanping, Lu, Fei, Zhang, Jingru, Zang, Shaolei, Yan, Shuxin, Ye, Jingjing, Xue, Fuzhong, Ma, Daoxin, Sun, Tao, Ji, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828578/ https://www.ncbi.nlm.nih.gov/pubmed/36197314 http://dx.doi.org/10.1002/cncr.34481

Ejemplares similares

Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
por: Li, Wei, et al.
Publicado: (2018)

PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway
por: Li, Banban, et al.
Publicado: (2021)

The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations
por: Tian, Tian, et al.
Publicado: (2015)

DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy (Adv. Sci. 19/2023)
por: Jia, Ruinan, et al.
Publicado: (2023)

DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2023)

Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis
por: Liu, Na, et al.
Publicado: (2015)

DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10–FGFR2 signaling
por: Yu, Shuang, et al.
Publicado: (2022)

Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation
por: Zang, Shaolei, et al.
Publicado: (2014)

Neuropathy correlated with imbalanced Foxp3/IL-17 in bone marrow microenvironment of patients with acute myeloid leukemia
por: Chen, Chen, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cells and γδT17 Cells Contribute to the Development of Gastric MALT Lymphoma in H. felis-Infected Mice
por: Zhao, Yanan, et al.
Publicado: (2020)

Aberrant T Helper 17 Cells and Related Cytokines in Bone Marrow Microenvironment of Patients with Acute Myeloid Leukemia
por: Tian, Tian, et al.
Publicado: (2013)

FZD7 regulates BMSCs-mediated protection of CML cells
por: Liu, Na, et al.
Publicado: (2015)

SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
por: Du, Yahui, et al.
Publicado: (2014)

Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
por: Zhu, Xunxun, et al.
Publicado: (2022)

NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
por: Zhong, Chaoqin, et al.
Publicado: (2021)

Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia
por: Zhou, Ying, et al.
Publicado: (2022)

Corrigendum: NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
por: Zhong, Chaoqin, et al.
Publicado: (2021)

Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia
por: Yang, Jiao, et al.
Publicado: (2022)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
por: Prochazka, Katharina T., et al.
Publicado: (2019)

Mitochondrial apoptosis-related gene polymorphisms are associated with responses to anthracycline-based chemotherapy in acute myeloid leukaemia
por: Meng, Guangqiang, et al.
Publicado: (2023)

Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches
por: Preuner, Sandra, et al.
Publicado: (2016)

The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia
por: Su, Xiuhua, et al.
Publicado: (2022)

Accurate Identification of Subclones in Tumor Genomes
por: Ahmadinejad, Navid, et al.
Publicado: (2022)

Characterization of hsa_circ_0004277 as a New Biomarker for Acute Myeloid Leukemia via Circular RNA Profile and Bioinformatics Analysis
por: Li, Wei, et al.
Publicado: (2017)

Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate
por: Wang, Ruiqing, et al.
Publicado: (2022)

The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
por: Chen, Ping, et al.
Publicado: (2015)

Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
por: Liu, Qiang, et al.
Publicado: (2014)

Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance
por: Zhang, Jingru, et al.
Publicado: (2018)

Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation
por: Wang, Dongmei, et al.
Publicado: (2023)

METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4
por: Li, Mingying, et al.
Publicado: (2022)

Subclonal heterogeneity and evolution in breast cancer
por: Mavrommati, Ioanna, et al.
Publicado: (2021)

Elevated Th22 Cells Correlated with Th17 Cells in Peripheral Blood of Patients with Acute Myeloid Leukemia
por: Yu, Shuang, et al.
Publicado: (2014)

Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones
por: Theunissen, Prisca M.J., et al.
Publicado: (2017)

TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
por: Pabst, Gabriel, et al.
Publicado: (2020)

Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
por: Wu, Yuyan, et al.
Publicado: (2023)

Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD(+) AML Cells
por: Feng, Panpan, et al.
Publicado: (2022)

Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes
por: Stucky, Andres, et al.
Publicado: (2022)

PRISM: methylation pattern-based, reference-free inference of subclonal makeup
por: Lee, Dohoon, et al.
Publicado: (2019)

Combating subclonal evolution of resistant cancer phenotypes
por: Brady, Samuel W., et al.
Publicado: (2017)

Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report
por: McGrath, Mary, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0k276p0hj39fjs8obbvpfskm6